Latest return on equity

Citius Oncology Return on equity

Citius Oncology (CTOR) return on equity with its verified observation date.

Direct answer

Citius Oncology's return on equity is -119.9%.

The verified market snapshot reports -119.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 22, 2026.

Get free Citius Oncology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Return on equity
-119.9%

Explore related company data

View Citius Oncology's market capitalizationView Citius Oncology's price-to-book ratioView Citius Oncology's 52-week price rangeView Citius Oncology's profit marginView Citius Oncology's debt-to-equity ratioView all Citius Oncology key metricsReturn to Citius Oncology profile